Comment on: McDonald et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011;34:1860-1862.

We have read with great interest the article recently published by McDonald et al. (1) replicating the initial study of Owen et al. (2), which demonstrated that high-sensitivity C-reactive protein (hs-CRP) levels are lower in hepatocyte nuclear factor 1-α (HNF1A) maturity-onset diabetes of the young (MODY) patients in comparison with other forms of diabetes, including type 2 diabetes. Five years ago, we published that the presence of clinical and metabolic features related to …